Compounds > 5-(4-piperidyl)isoxazol-3-ol
Page last updated: 2024-09-03

5-(4-piperidyl)isoxazol-3-ol and tert-butylbicyclophosphorothionate

5-(4-piperidyl)isoxazol-3-ol has been researched along with tert-butylbicyclophosphorothionate in 1 studies

Compound Research Comparison

Studies
(5-(4-piperidyl)isoxazol-3-ol)		Trials
(5-(4-piperidyl)isoxazol-3-ol)		Recent Studies (post-2010)
(5-(4-piperidyl)isoxazol-3-ol)		Studies
(tert-butylbicyclophosphorothionate)		Trials
(tert-butylbicyclophosphorothionate)		Recent Studies (post-2010) (tert-butylbicyclophosphorothionate)
210446506

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hevers, W; Korpi, ER; Lüddens, H; Picard, R; Rabe, H; Uusi-Oukari, M1

Other Studies

1 other study(ies) available for 5-(4-piperidyl)isoxazol-3-ol and tert-butylbicyclophosphorothionate

ArticleYear
Coupling between agonist and chloride ionophore sites of the GABA(A) receptor: agonist/antagonist efficacy of 4-PIOL.
    European journal of pharmacology, 2000, Dec-15, Volume: 409, Issue:3

    Topics: Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; GABA Agonists; Humans; Ionophores; Isoxazoles; Ligands; Male; Piperidines; Rats; Rats, Wistar; Receptors, GABA-A

2000